EuroEyes International Eye Clinic Limited (HKG:1846)
Hong Kong · Delayed Price · Currency is HKD 2.600
0.00 (0.00%)
Jun 5, 2026, 2:51 PM HKT
HKG:1846 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 54.45 | 82.29 | 131.24 | 89.47 | 133.56 |
Depreciation & Amortization | 126.75 | 112.06 | 87.21 | 80.58 | 74.61 |
Other Amortization | 0.94 | 0.15 | 0.14 | 0.14 | 0.05 |
Loss (Gain) From Sale of Assets | -2.67 | 1.08 | 0.38 | -0.21 | 0.29 |
Asset Writedown & Restructuring Costs | - | 11 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -0.14 | -0.51 |
Stock-Based Compensation | - | 1.56 | 2.23 | 2.68 | 11.33 |
Other Operating Activities | 16.9 | -22.04 | -32.25 | 25.89 | 22.81 |
Change in Accounts Receivable | -7.23 | 1.42 | 0.95 | 1.98 | 0.91 |
Change in Inventory | 6.07 | -3.32 | 29.56 | 8.23 | 8.04 |
Change in Accounts Payable | -2.77 | 5.62 | -30.61 | -10.22 | 3.76 |
Change in Unearned Revenue | -4.01 | 0.87 | 2.8 | -16.62 | 1.4 |
Change in Other Net Operating Assets | 5.33 | 7.06 | 0.2 | 27.27 | 17 |
Operating Cash Flow | 193.75 | 197.75 | 191.86 | 209.05 | 273.26 |
Operating Cash Flow Growth | -2.02% | 3.07% | -8.22% | -23.50% | 248.29% |
Capital Expenditures | -45.64 | -80.34 | -88.92 | -56.31 | -43.98 |
Sale of Property, Plant & Equipment | 4.02 | 2.62 | - | 0.63 | 0.09 |
Cash Acquisitions | -70.87 | -6.12 | -90.73 | -91.45 | - |
Sale (Purchase) of Intangibles | - | - | -0.64 | - | -0.57 |
Investment in Securities | - | - | - | 15.32 | -15.44 |
Other Investing Activities | -0.98 | - | - | - | - |
Investing Cash Flow | -113.47 | -83.83 | -180.29 | -131.81 | -59.9 |
Long-Term Debt Repaid | -77.19 | -73.17 | -59.31 | -63.19 | -44.6 |
Net Debt Issued (Repaid) | -77.19 | -73.17 | -59.31 | -63.19 | -44.6 |
Repurchase of Common Stock | -18.41 | -35.8 | - | -8.36 | -15.28 |
Common Dividends Paid | -19.63 | -27.85 | -39.68 | -33.1 | -9.84 |
Other Financing Activities | -0.75 | - | -3.78 | 2.43 | 0.54 |
Financing Cash Flow | -115.97 | -136.82 | -102.76 | -102.22 | -69.18 |
Foreign Exchange Rate Adjustments | 78 | -44.09 | 31.84 | -41.09 | -60.37 |
Net Cash Flow | 42.31 | -66.98 | -59.35 | -66.07 | 83.81 |
Free Cash Flow | 148.11 | 117.41 | 102.94 | 152.74 | 229.28 |
Free Cash Flow Growth | 26.14% | 14.06% | -32.61% | -33.38% | 471.51% |
Free Cash Flow Margin | 18.61% | 16.41% | 14.41% | 25.03% | 36.23% |
Free Cash Flow Per Share | 0.46 | 0.36 | 0.31 | 0.46 | 0.70 |
Cash Income Tax Paid | 53.65 | 51.07 | 93.1 | 18.79 | 33.67 |
Levered Free Cash Flow | 229.02 | 78.62 | 91.1 | 175.68 | 198.88 |
Unlevered Free Cash Flow | 234.81 | 84.89 | 97.16 | 180.12 | 203.56 |
Change in Working Capital | -2.61 | 11.65 | 2.9 | 10.62 | 31.11 |